Journal Articles
Burgener, Sabrina Sofia, Milner, Mark Thomas, Dey, Shoumit, Morgan, Pooranee K., Blackmore, Daniel G., Frampton, Emmanuelle, Miller, Gregory, Duarte de Oliveira, Monalisa, Kenney, Kirsten Myra, Bajracharya, Rinie, Baumgartner, Ulrich, Collins, Thomas J. C., Xiong, Zherui, Nguyen, Quan, Meikle, Peter J., Bodea, Liviu-Gabriel, Clouston, Andrew, Boucher, Dave, Götz, Jurgen, Murphy, Andrew J., Kaye, Paul M. and Schroder, Kate (2025). Caspase-1 self-terminates protease activity to enforce homeostasis and prevent inflammasome-driven diseases. BioRxiv. doi: 10.1101/2025.04.28.651119
Kordowski, Anja, Mulay, Onkar, Tan, Xiao, Vo, Tuan, Baumgartner, Ulrich, Maybury, Mellissa K., Hassall, Timothy, Harris, Lachlan, Nguyen, Quan and Day, Bryan W. (2025). Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk. Acta Neuropathologica Communications, 13 (1) 35. doi: 10.1186/s40478-025-01952-x
Li, Yuchen, Lim, Chaemin, Dismuke, Taylor, Malawsky, Daniel S., Oasa, Sho, Bruce, Zara C., Offenhäuser, Carolin, Baumgartner, Ulrich, D’Souza, Rochelle C. J., Edwards, Stacey L., French, Juliet D., Ock, Lucy S. H., Nair, Sneha, Sivakumaran, Haran, Harris, Lachlan, Tikunov, Andrey P., Hwang, Duhyeong, Alicea Pauneto, Coral Del Mar, Maybury, Mellissa, Hassall, Timothy, Wainwright, Brandon, Kesari, Santosh, Stein, Gregory, Piper, Michael, Johns, Terrance G., Sokolsky-Papkov, Marina, Terenius, Lars, Vukojević, Vladana, McSwain, Leon F. ... Day, Bryan W. (2025). Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179. Nature Communications, 16 (1) 1091, 1091. doi: 10.1038/s41467-024-54861-3
Kashani, Elham, Schnidrig, Désirée, Gheinani, Ali Hashemi, Ninck, Martina Selina, Zens, Philipp, Maragkou, Theoni, Baumgartner, Ulrich, Schucht, Philippe, Rätsch, Gunnar, Rubin, Mark A., Berezowska, Sabina, Ng, Charlotte K.Y. and Vassella, Erik (2023). Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors. Neuro-Oncology, 25 (4), 662-673. doi: 10.1093/neuonc/noac220
Alhalabi, Obada T., Fletcher, Michael N C, Hielscher, Thomas, Kessler, Tobias, Lokumcu, Tolga, Baumgartner, Ulrich, Wittmann, Elena, Schlue, Silja, Rahman, Mona GöttmannShaman, Hai, Ling, Hansen-Palmus, Lea, Puccio, Laura, Nakano, Ichiro, Herold-Mende, Christel, Day, Bryan W., Wick, Wolfgang, Sahm, Felix, Phillips, Emma and Goidts, Violaine (2022). A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma. Neuro-Oncology, 24 (1), 39-51. doi: 10.1093/neuonc/noab158
Lenin, Sakthi, Ponthier, Elise, Scheer, Kaitlin G., Yeo, Erica C. F., Tea, Melinda N., Ebert, Lisa M., Mansilla, Mariana Oksdath, Poonnoose, Santosh, Baumgartner, Ulrich, Day, Bryan W., Ormsby, Rebecca J., Pitson, Stuart M. and Gomez, Guillermo A. (2021). A drug screening pipeline using 2D and 3D patient-derived in vitro models for pre-clinical analysis of therapy response in glioblastoma. International Journal of Molecular Sciences, 22 (9) 4322, 1-27. doi: 10.3390/ijms22094322
Conference Paper
Bradbrook, K. A., Baumgartner, U., Smith, F. M., Johnston, R., Harris, L., Hoyte, S., Lwin, Z., Alexander, H., Jeffree, R. and Day, B. W. (2023). A Development And Characterisation Of The Qcell-R Recurrent Glioblastoma Primary Cell Line Resource: Models To Drive Breakthrough Discoveries In Brain Cancer. 18th Meeting of the European Association of Neuro-Oncology, Rotterdam, Netherlands, 21-24 September 2023. Cary, NC United States: Oxford University Press. doi: 10.1093/neuonc/noad137.401